Skip to content

Role of tranexamic acid via intravenous and irrigation fluid route in controlling TURP-associated bleeding

Efficacy of Intravenous and Topical Tranexamic Acid to Control Perioperative Blood Loss in Bipolar TURP - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075515
Enrollment
90
Registered
2024-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: I/V Tranexamic Acid Group: 1gm I/V Tranexamic acid to be administered 20 min before surgery. Intervention2: Irrigation Fluid Tranexamic Acid Group: 500 mg of Tranexamic acid will be add

Sponsors

BLDE (Deemed to be University), Shri B M Patil Medical College Hospital & Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Bothersome LUTS and proven prostatic enlargement based on digital rectal examination and abdominal ultrasonography with gland size 40-100 cc 2. Age 50-90 years

Exclusion criteria

Exclusion criteria: 1. History or evidence of prostate disease other than BPH, previous prostate surgery 2. Severe cardiopulmonary disease 3. Patients requiring treatment with anti-platelets, or anticoagulants in the immediate perioperative period and severe medical conditions such as liver disease, or bleeding disorders 4. End Stage Renal Disease

Design outcomes

Primary

MeasureTime frame
1.Drop in the Haemoglobin and Hematocrit level 2. Any Change in the Volume of irrigation fluid used after TURP 3. complications- specifically Deep Vein Thrombosis.Timepoint: 4 Hrs, 24hrs and 1 week.

Secondary

MeasureTime frame
Incidence of Clot retention or hematuria or deep vein thrombosisTimepoint: 1 month 3 months

Countries

India

Contacts

Public ContactManoj Kiran Vaidya

BLDE Deemed to be University

vinayuro@rediffmail.com9448897564

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026